Fudan University — Clinical Trial Pipeline

Fudan University has 12 registered trials in the index.

Trials (12)

• Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer N/A · Fudan University
• Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients Phase 3 · Fudan University
• Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer Phase 2 · Fudan University
• Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase Phase 2 · Fudan University
• Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) Phase 3 · Fudan University
• Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Phase 2 · Fudan University
• Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant Treatment Phase 2 · Fudan University
• A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer N/A · Fudan University
• Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach N/A · Fudan University
• Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue Sarcomas Phase 3 · Fudan University
• The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer N/A · Fudan University
• Cola Ingestion for Esophageal Bolus Impaction N/A · Fudan University

Related landscapes

• Breast Cancer
• Hematological Toxicity
• Targeted Therapy
• TNBC
• Thyroid Cancer

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.